Abstract: Memapsin 2 (BACE1, b-secretase), a membrane aspartic protease, functions in the cleavage of brain b-amyloid precursor protein (APP) leading to the production of b-amyloid. Because the excess level of b-amyloid in the brain is a leading factor in Alzheimer's disease (AD), memapsin 2 is a major therapeutic target for inhibitor drugs. The substrate-binding cleft of memapsin 2 accommodates 12 subsite residues, from P 8 to P 4 0 . We have determined the hydrolytic preference as relative k cat /K M (preference constant) in all 12 subsites and used these data to establish a predictive algorithm for substrate hydrolytic efficiency. Using the sequences from 12 reported memapsin 2 protein substrates, the predicted and experimentally determined preference constants have an excellent correlation coefficient of 0.97. The predictive model indicates that the hydrolytic preference of memapsin 2 is determined mainly by the interaction with six subsites (from P 4 to P 2 0 ), a conclusion supported by the crystal structure B-factors calculated for the various residues of transition-state analogs bound to different memapsin 2 subsites. The algorithm also predicted that the replacement of the P 3 , P 2 , and P 1 subsites of APP from Val, Lys, and Met, respectively, to Ile, Asp, and Phe, respectively, (APP IDF ) would result in a highest hydrolytic rate for b-amyloid-generating APP variants. Because more b-amyloid was produced from cells expressing APP IDF than those expressing APP with Swedish mutations, this designed APP variant may be useful in new memapsin 2 substrates or transgenic mice for AD studies.
Introduction
Memapsin 2 (BACE1, b-secretase) is a membraneanchored aspartic protease. Although this enzyme is ubiquitously present in many mammalian organs, its functions in the brain are best studied. One of the most important physiological functions of memapsin 2 is the cleavage of a brain membrane protein b-amyloid precursor protein (APP). The hydrolytic product of APP C-terminal fragment is cleaved again by c-secretase to generate b-amyloid peptide (Ab). Ab has been shown to downregulate the synaptic activity in neurons.
1,2 Also, memapsin 2-produced APP N-terminal fragment is involved in the trimming of neurons and axons in the brain. 3 However, because excess levels of brain Ab are intimately related to the pathogenesis of Alzheimer's disease (AD), 4 there has been intensive effort to develop inhibitor drugs against memapsin 2. 5 Important to such effort is the detailed knowledge on the specificity preference of this protease. In addition, there has been interest in other possible physiological functions of memapsin 2 that need to be taken into consideration when developing inhibitors. The protease is known to be involved in the processing of neuregulin 1 during neuronal myelination in prenatal mice. 6, 7 Other proteins processed by memapsin 2 include the beta-subunits of voltage-gated sodium channels (VGSC-bs), [8] [9] [10] alpha 2,6-sialyltransferase I (ST6GalI), 11 P-selectin glycoprotein ligand-1 (PSGL-1), 12 interleukin-1 receptor II (IL-IR2), 13 low-density lipoprotein receptor-related protein (LRP), 14 and amyloid-beta precursor-like proteins (APLPs). [15] [16] [17] The physiological significance of most of these cleavages is not clear, and only some of the memapsin 2 cleavage sites on these proteins have been determined. These studies have mostly been done in cells overexpressing potential substrate proteins that may lead to the enhanced cleavage of some nonphysiological substrates from their increased availability or distorted localization in subcellular compartments. Also, in cellular or in vivo experiments, memapsin 2 cleavage sites may be subjected to additional proteolysis by other cellular proteases, thus leading to the erroneous identification of memapsin 2 processing site, such as the case of alpha 2,6-sialyltransferase. 11, 18 For these reasons, a clear understanding of memapsin 2 specificity with the ability to predict its activity toward different potential cleavage sites would be of assistance to the studies of physiological functions of this protease. The polypeptide chain of memapsin 2 comprises a N-terminal ectocatalytic domain, a transmembrane domain, and a C-terminal cytosolic domain. 19 The catalytic domain is homologous to aspartic proteases of the pepsin superfamily in both the amino acid sequence 19 and in tertiary structure. 20 The activity of memapsin 2 is optimal near pH 4, 21 as is consistent with its function primarily within endosomal vesicles. The crystal structure of the catalytic domain shows that, like other aspartic proteases, memapsin 2 has a long substrate-binding cleft between the N-and C-terminal lobes that occupies nearly the entire width of the molecule. 20 The binding positions of transitionstate analogs in the protease indicate that the substrate-binding cleft can accommodate 11-12 residues, with seven to eight residues at the N-terminus side (subsites P 8 -P 1 ) and four at the C-terminal side (subsites P 1 0 -P 4 0 ). 20, 22 We reported the residue preferences on 19 amino acids in eight memapsin 2 subsites, from S 4 to S 4 0 , which are the subsites commonly present in aspartic proteases. 23 We also reported that memapsin 2 possesses three to four additional subsites and determined preferences in three of these sites, S 7 , S 6 , and S 5 . 24 These data, determined as relative k cat /K M , which defines the relative efficiency of peptide bonds hydrolyzed by memapsin 2, established that this protease has a somewhat broad specificity in all subsites. Because these data represent the most complete specificity information of a nonstringent aspartic protease in kinetic constants, we asked if the contribution of different subsites to the determination of substrate cleavage sites can be expressed in quantitative terms and can be further developed as a predictive model for the probability of cleavage sites in any peptide substrate. Here, we describe an empirical model to quantitate the subsite contributions and predict the likelihood of cleavage of a peptide by memapsin 2.
Results
Complete residue preference on subsites P 5 -P 8
To assess the contribution of all subsites on memapsin 2 catalysis, we need a complete set of subsite specificity data. Although the residue preferences for eight subsites, from P 4 to P 4 0 , are complete, 23 only preliminary specificity data are available on four later discovered subsites P 5 to P 8 . 24 Thus, the first task was to determine the complete residue preference in these four subsites using the same strategy as previously described. 23 Briefly, the initial cleavage rates of peptide substrates in a mixture by memapsin 2 were determined using ESI-TOF mass spectrometry. The relative rates under the experimental conditions were proportional to the relative k cat /K M (preference index) values. 25 Thus, peptide substrates differing from one another only by residues in a single subsite yielded relative preference for these residues. Preference index values for residues in subsites P 8 , P 7 , P 6 , and P 5 are shown in Figure 1 (A). Among these four subsites, amino acids in P 6 have the most effect on the substrate hydrolysis and tryptophan (W) and phenylalanine (F) are most favored.
In the other three subsites, the differences among the residues are less noticeable. We observed that basic amino acids are generally unfavorable in at least three subsites, P 5 , P 6 , and P 7 . Although there is a general agreement between the current data and the previous preliminary data, 24 the preference index values for tryptophan and basic amino acids were significantly different. For this reason, we used the stable-isotope-assisted MALDI-TOF mass spectrometry for better accuracy of the kinetic results. In the experimental design [ Fig. 1(B) ], peptides (P 6 -1, P 7 -1, and P 8 -1) containing mixed amino acids at subsite to be tested were labeled with either N-acetoxy-D 0 -succinimide or N-acetoxy-D 3 -succinimide. 26 The D 3 -acelyated peptides were subjected to memapsin 2 hydrolysis and mixed with equal amount of D 0 -acelyated-modified same peptide. The two isotopes in each sample were determined in MALDI-TOF mass spectrometer. The D 3 data represent the hydrolytic rates, and the D 0 data serve as an internal standard. The relative hydrolytic rates, which represent the relative k cat /K M values 25 of P 6 , P 7 , or P 8 , are shown in Figure 1 (C). The isotope-MALDI-TOF study initially included P 5 , but data from this subsite were not recovered. In spite of this loss, a comparison of data from P 6 , P 7 , or P 8 using these two methods clearly established that the relative preferences are in good agreement.
Comparison of the kinetics for peptides derived from memapsin 2 protein substrates
We studied the hydrolytic efficiency of APP and other reported substrates ( (Table I ). hydrolyzes the substrate peptide set with a wide range of efficiency.
An algorithm for memapsin 2 catalytic specificity
Information on the complete subsite specificity and kinetic data from substrate peptide set permitted us to address the question of whether these data can generate a quantitative model to assess the catalytic efficiency of potential memapsin 2 cleavage sites. We used the data for the substrate peptide set as a learning set to build and test an algorithm for relating the experimentally determined relative k cat /K M values to the calculated cleavage efficiency values.
The agreement between these two sets of values served to evaluate the competence of the model. In developing the algorithm, we assumed that all the side chains of the substrate are equal in accessibility by memapsin 2, and that the contribution of each side chain in cleavage efficiency is independent of other side chains. Also, we assumed that the contribution of each subsite to the cleavage efficiency is different from that of the other subsites, as suggested from the different stringency on residue specificity in different subsites. These assumptions led us to an equation similar to a weighted geometric mean of the various specificities because we expected the effects of the individual subsites to be multiplicative. The resulting equation is as follows:
where Q is the arbitrary value for memapsin 2 cleavage efficiency, a i is the experimentally determined relative k cat /K M value (Supporting Information Table I ) of the amino acid at P i subsite position, and w i is the weighting factor of that particular subsite. The w i values were determined by nonlinear regression to achieve a maximal correlation coefficient value between the Q values and the actual kinetic data of the substrate peptide set. The optimized w i values are shown in Table II , and corresponding Q values for the substrate peptide set are 
Relative k cat /K M b P 8 P 7 P 6 P 5 P 4 P 3 P 2 P 1 * c P 1 (3)- (6) VGSC-b1, b2, b3, and b4 represent b1-b4 subunits of voltage-gated sodium channels. (7) ST6GalI represents a-2,6-sialyltransferase I. (8) shown in Table I . During the optimization process, we found that only six subsites, P 4 -P 2 0 , significantly influenced the calculated Q values; thus, the outside subsites were dropped from the further calculations. A plot of the Q values and the relative k cat /K M data showed a linear correlation (Fig. 2) with a correlation coefficient of 0.97. The correlation of the observed and calculated data in Figure 2 was further validated by a ''leave-one-out cross validation,'' which is one type of K-fold cross validation. Under this test, the mean correlation coefficient was 0.96 6 0.012. The closeness of the mean correlation coefficient to the original value and the narrow deviation of the mean clearly established the validity of the algorithm.
To test this algorithm, we selected a 15-residue peptide cerebellin (GSAKVAFSAIRSTNH), which is not a natural substrate of memapsin 2. This peptide was chosen because it is small enough to be unbiased in specific tertiary structures yet contains enough residues to be recognized by multiple subsites of memapsin 2. The application of the algorithm predicted a distinct cleavage site at the PheSer bond (Table III) (Fig. 3) , which are assigned to the fragment GSAKVAF and SAIRSTNH, the N-terminal and C-terminal products generated from the predicted cleavage site, respectively. The k cat /K M value determined for the cleavage of this site was 0.14 s À1 M À1 . Overall, these results confirmed the predicted cleavage site using the algorithm.
Determine B-factor values of residues in memapsin 2 subsites
Because the efficiency of substrate hydrolysis is related to the transition-state binding, it was of interest to obtain physical data on binding intensity of inhibitor residues in the subsites of memapsin 2 for comparison with the kinetic data of the subsites. Several crystal structures of memapsin 2 complex to inhibitors are available in the database. Of these, five inhibitors are transition-state analogs in which the scissile peptide bonds were replaced by a transition-state isostere. We reasoned that the B-factor (crystallographic temperature factor) of the inhibitor side chains, which is an indicator for the motion or variability in the structure, should be inversely related to the transition-state binding intensity of these residues and may also mirror the parameters determined by enzyme kinetics. The normalized B-factor values of each side chain in the five inhibitors were determined and shown in Figure 4 . There is a significant increase in the side chain B-factors for positions P 3 0 and P 4 0 when compared with the other inhibitor subsites. This is consistent with our observation that subsites P 3 0 and P 4 0 do not have significant influence on the calculated k cat /K M for any peptide. The correlation of the normalized reciprocal weighting factors (Fig. 4 , heavy line) with the aggregate of the B-factors is good except for position P 1 0 . The reciprocal of the weighting factor for subsite P 1 0 developed for the algorithm is much higher than the other subsite weights and higher than the comparable B-factors. Consequently, in the predictive calculations, subsite Design an APP mutant for maximal production of amyloid-beta
The results above show that the mutations of P 2 Lys and P 1 Met in APP WT to P 2 Asn and P 1 Leu, respectively (APP SW ), increased the k cat /K M value by 477-fold (Table I) . Because the P 0 residues are not changed, both APP WT and APP SW produce the same amyloid-b (Ab) peptides, and this greatly enhanced production leads to an early onset of AD in APP SW mutation. With the availability of the algorithm described above, it was of interest to design a highly efficient memapsin 2 cleaving APP mutant with new residue mutations only on the P subsites, thus it would still produce the native Ab. The algorithm predicted that the mutation of residues in APP WT from P 3 Val, P 2 Lys, and P 1 Met to P 3 Ile, P 2 Asp, and P 1 Phe, respectively (APP IDF ), would increase the k cat /K M value by about 849-fold, about 1.7 times higher than that for APP SW . To investigate the production of Ab by APP IDF in the cells, we mutated (Table II) . The reciprocal weighting factor has been normalized to the aggregate of the B-factors. 
Discussion
The determination of subsite specificity of aspartic proteases usually requires many kinetic analyses. Because most of these proteases have eight or more subsites and have nonstringent specificity, very few subsite specificity of these enzymes have been completely determined. For memapsin 2, the residue preference, expressed as relative k cat /K M values, is now known for 12 subsites, from P 8 to P 4 0 . Therefore, these data on memapsin 2 represent the first complete kinetic assessment of the subsite preference of an aspartic protease, which offers a new opportunity for dissecting the influence of subsite residues on hydrolytic activity and establishing an algorithm for predicting memapsin 2 activity. The general applicability of the algorithm is supported by a good correlation coefficient between the predicted and experimentally determined preference constants by the result in a test substrate cerebellin. We have used the algorithm to predict memapsin 2 cleavage activity of several proteins of interest. First, four peptides containing sequences from the reported memapsin 2 substrates (Table I, Nos. 3, 5 , 11, and 12) were very poor substrates. The fact that the relative k cat /K M value of APP WT near the values for these four peptides seems to suggest that the functions of memapsin 2 in vivo do not require substrates with highly favorable bonds, as both enzyme and substrates are membrane anchored so the substrate is well positioned to be cleaved. This line of argument is supported by our observation that the memapsin 2-cleaved bonds in these protein substrates are located in a region from 10 to 31 amino acid residues from the membrane (Table I) . Our data also clearly show that subsite specificity is the main factor for cleavage efficiency, once the substrate is in the protease's effective range. For example, the cleavage positions of APP WT and APP SW are both 29 residues from the membrane yet differ in hydrolytic efficiency by near 500 times. Another interesting point related to the above discussion is that memapsin 2 cleavage sites in APP WT (Table I , number 1) and APP E11 (Table I , number 12) are present on the same APP molecule, thus should be competing cleavage sites. The cleavage of APPE 11 produces a shorter peptide, Glu11-Ab, after the c-secretase cleavage. 27 Based on the relative k cat /K M of these two sites, the production ratio of Ab to Glu11-Ab would be about 50 to 1 from APP WT . However, in cells producing APP SW , this ratio would be about 25,000 to 1, greatly diminishing the production of Glu11-Ab and its possible physiological roles.
Second, two APP homologs, APLP1 and APLP2, are known to be cleaved by memapsin 2. [15] [16] [17] However, the actual cleavage sites have not been determined. We have used the algorithm to predict the potential memapsin 2 cleavage sites in the region of 55 residues adjacent to the membrane in the ectodomains of these proteins. For APLP2, two potential cleavage sites (sites 1 and 2 in Table IV) were predicted at 40 and 34 residues from the membrane. The estimated cleavage efficiency is about the same as that of the b-site of APP WT (Table I) . Sites 3 and 4 (Table IV) are about 50 to 200 times lower than the values for sites 1 and 2. Thus, memapsin 2 cleavage of sites 3 and 4 seems less probably even though these sites are located in the effective cleavage range. For APLP1, the algorithm predicted no efficient cleavage site with the highest kinetic value is only 1/4000 in cleavage efficiency when compared with the b-site of APP WT (Table IV) . These results suggest that APLP1 is not an effective substrate of memapsin 2. Third, prostaglandin E2 synthetase 2 has been reported to be cleaved by memapsin 2. 28 The proposed cleavage site, however, is extremely unfavorable (site 14, Table IV ) and is unlikely to be significantly cleaved by memapsin 2. Two nearby sites (sites 15 and 16, Table IV ) have much better values for cleavage preference and are more likely to be the probable sites for memapsin 2 processing. The usefulness of the current algorithm prediction is also illustrated in the case of memapsin 2 cleavage site in alpha 2,6-sialotransferase 1. The cleavage site initially reported (site 18, Table IV) 11 was three residues away from the actual cleavage site later determined (site 17, Table IV) . 18 The predicted kinetic values (Table IV) show that site 17 is favorable and site 18 is extremely unfavorable for memapsin 2 cleavage. The algorithm described here was developed based on the assumption that the recognition of each side chain by a protease subsite is independent and the peptide substrates have random conformation in solution. The very high correlation between the predicted preference constants (relative k cat /K M ) and the actual data derived from in vitro experiments appears to support the assumption. In vivo substrates of memapsin 2 are proteins that conceivably may retain some conformation in the peptide strands near the cleavage sites and may differ from the in vitro rates. However, the fact that substrate analogs bind to the memapsin 2 active site in extended conformation argues for an extended, denatured state of the peptide strands at least locally near the cleavage sites. Such a ''local denaturation'' of the cleavage sites could be facilitated by the acidic environment inside of the endosomal vesicles where the majority of memapsin 2 activity is manifested. 29, 30 We observed an interesting correlation between the current algorithm and temperature (B-) factors of the side chains in the crystal structures of transition-state analog inhibitors complex to memapsin 2. In spite of limited residue variation in the inhibitors bound to the protease (see structures in Materials and Methods), there is a clear similarity in the normalized B-factors of the side chains and the inverse values of the weighting factors determined in this work (Fig. 4) . The B-factor values in this case reflect the degree of freedom in the motion for the side chains and should be inversely related to the tightness of their binding in different subsite pockets. Because these inhibitors are transition-state analogs, the B-factor values of the individual subsites may reflect inversely their contributions to the transition-state binding during the catalysis and to the kinetic parameter k cat . Although the weighting factors are empirically determined from the formulation of our algorithm, the similar trend of these two sets of values suggests that the weighting factors are influenced in large extent by the contribution of individual subsites to the overall k cat of the substrates. We noticed that the B-factor values for subsites P 3 0 and P 4 0 were much larger than those of the other subsites (Fig. 4) . This is in agreement with the observation that the inclusion of these subsites in the calculation did not improve the outcome of the prediction of cleavage preference. As can be seen in Figure 4 , the agreement between B-factor and weighting factor is poorest at subsite P 1 0 . Different computational schemes attempted did not produce an equally competent algorithm with a higher weighting factor for subsite P 1 0 .
We tentatively suggest that this subsite may have other mechanistic roles in memapsin 2 catalysis, thus is not strictly related to the transition-state binding.
In view of the excellent correlation coefficient for the experimental and prediction values (Fig. 2) , we feel that the impact of this discrepancy on the overall ability of the algorithm to predict cleavage preference is relatively small. The kinetic data on natural substrates of memapsin 2 offer an interesting range of hydrolytic efficiency of about 35,000-fold variation (Table I ). The wild-type APP WT , which is the best established physiological substrate of memapsin 2, is in fact among the substrates with relatively low hydrolytic efficiency by memapsin 2. APP IDF and APP SW , both generate native Ab, increase the k cat /K M value by 849 and 479 times from that of APP WT , respectively. These comparisons argue for the hypothesis that the structural mutations to attain the highest cleavage efficiency of APP as a memapsin 2 substrate have not been subjected to survival selection in evolution. This may be because other criteria, such as regulation of Ab production, are more important criteria for evolutionary selection.
The design of APP IDF further demonstrated the potential application of the algorithm model. The predicted hydrolytic efficiency of APP IDF by memapsin 2 is 1.7-fold of that for APP SW . In cellular experiments, we observed that the production of Ab from APP IDF up to 1.5-fold that from APP SW . Up to now, APP SW has been the APP mutant that produces the highest amount of Ab and its sequence has been used in peptide substrates for memapsin 2 assays. APP SW has also been used to produce a number of transgenic mouse strains 31, 32 that manifest both brain amyloid plaques and loss of cognitive functions upon aging. These mouse strains are widely used as experimental models for AD in human. Our current results indicate that peptides containing APP IDF would be more efficient substrates for memapsin 2 than those containing APP SW sequences, and it would be of interest to study transgenic mouse strains with the APP IDF mutations as animal models of AD. The probability of a clinical observation of an early onset of AD with APP IDF mutations is probably very small because five mutations need to occur for the conversion of APP WT to APP IDF , when compared with the formation of APP SW would need only two mutation steps.
Materials and Methods
Materials a-Cyan-4 hydroxycinnamic acid, D 0 -and D 6 -form acetic anhydride, and N-hydroxysuccinimide were purchased from Sigma. Peptide (Des-Ser1)-cerebellin was purchased from Bachem (Bubendorf, Switzerland). All peptides derived from memapsin 2 potential substrates were synthesized by GenScript (Piscataway, NJ). The ectodomain of human memapsin 2 was expressed and purified as described previously. 20 Monoclonal anti-APP antibody 1560, MAB348 (22C11), and polyclonal anti-APP antibody 5352 were purchased from Millipore (Billerica, MA). Monoclonal anti-actin antibody was purchased from Abcam (Cambridge, MA).
Design of the defined substrate mixtures
Peptide sequence RK (P 10 )T(P 9 )E(P 8 )E (P 7 )I(P 6 )S (P 5 )E(P 4 )V(P 3 )N(P 2 )L(P 1 )*D(P 1 0 )A(P 2 0 )E(P 3 0 )F(P 4 0 ), corresponding to the amino acid sequence of APP with Swedish mutation from P 10 to P 4 0 , was used to be a template to study residue preferences in substrate mixtures (* denotes the cleavage site). Four sets of separate substrate mixtures were synthesized by Synpep (Dublin, CA): RKTEEI-[X]-EVNL*DAEF, RKTEE-[X]-SEV-NL*DAEF, RKTE-[X]-ISEVNL*DAEF, and RKT-[X]-EISEVNL*DAEF. These four sets contain residue mixture (represented by X) of 19 amino acids (cysteine is not included as it spontaneously forms disulfide in kinetic measurements and also in protein substrates cysteines are in disulfides, which are not cleaved by memaspin 2) at positions corresponding to P 5 , P 6 , P 7 , and P 8 , respectively. A peptide derived from APP SW , RKTEEI-SEVNL*DAEF, was also added to each mixture to serve as an internal standard. Three additional sets of mixtures used previously 24 were also used here, RTEE-[X]-SEVNL*AAEF for the study of P 6 subsite, RTE-[X]-ISEVNL*AAEF for the study of P 7 subsite, and RT-[X]-EISEVNL*AAEF for the study of P 8 subsite (they will be referred to as peptide mixtures P 6 -1, P 7 -1, and P 8 -1, respectively).
Kinetic analysis of subsite specificity using ESI-TOF mass spectrometry Substrate mixtures were dissolved at 10 mg mL À1 in DMSO and were further diluted to 10 lM in 0.1M MOPS buffer (pH 4.0). The reactions were initiated by the addition of memapsin 2; aliquots were removed at time intervals and quenched by formic acid. Quantitative analysis was conducted by ESI LC/MS. The system was composed of an Agilent 1100 HPLC, a Clipeus 50 mm Â 5 mm C-18 column, and a Bruker MicroTOF ESI-MS. Relative product formed per unit time was calculated similar as previously described. 23 A relative catalytic efficiency (k cat /K M ) of 1.0 was assigned to the internal standard peptide, APP SW . Therefore, the relative k cat /K M of any other substrate is determined by comparing its pseudo first-order rates of cleavage to that of the APP SW peptide. For convenience of discussion, the relative k cat /K M value is also referred to as ''preference index.'' Kinetic analysis of subsite specificity using stable isotope-assisted MALDI-TOF mass spectrometry N-acetoxy-D 0 (D 3 )-succinimide was synthesized from N-hydroxysuccinimide and D 0 (D 6 )-form acetic anhydride as previously described. 26 Each of the peptide mixture (P 6 -1, P 7 -1, and P 8 -1) was equally divided and incubated with either N-acetoxy-D 0 -succinimide or N-acetoxy-D 3 -succinimide in 25 mM ammonium bicarbonate, pH 7.5, for 3 h. D 0 -or D 3 -aceylatedmodified peptide mixtures were individually diluted into 0.1M MOPS, pH 4.0, to obtain a final concentration of 6 lM. At room temperature, an aliquot of memapsin 2 was added to the D 3 -modified sample. At different time points, an aliquot sample was taken out, quenched by formic acid, and pooled with equal volume of the D 0 -labeled sample. Samples of 0.5 lL were each combined with equal amount of saturated a-cyan-4 hydroxycinnamic acid matrix in 50% acetonitrile/0.1% TFA and subjected to Bruker Ultraflex MALDI-TOF mass spectrometer. Relative product formation was calculated as the ratio of the reduction of substrate's signal intensity by comparing the amount of D 3 to its reference D 0 . The relative k cat /K M was calculated as described above.
Plasmid construction and mutagenesis
APP (770 isoform) was subcloned into pSecTag vector. Different mutations flanking the b-cleavage site (P 3 -P 1 ) APP SW , APP IDF , and APP MDL were generated by Stratagene QuikChange Site-Directed Mutagenesis Kit and individually confirmed by DNA sequencing.
Cell culture, transfection, and analysis of APP processing products
Mouse neuronal CAD cell line was cultured with DMEM/F12 media (Invitrogen, Carlsbad, CA). Transient transfections were performed using Roche Fugene HD according to the manufacture's instruction. Twenty-four hours after transfection, total cell lysate and cell media were collected. Ab level in media was assayed by Ab [ ] Human Fluorimetric ELISA Kit (Invitrogen). Conditioned media or total cell lysate from the transiently transfected cells were subjected to Western blot with antibody against full-length APP, APP's proteolytic products, and b-actin.
Calculation of B-factors of residues in the subsites of memapsin 2-inhibitor complexes Crystal structures of memapsin 2-inhibitor complexes from PDB IDs 1FKN, 1M4H, 1XN3, 2ZHR, and 1XN2 were included in the ligand B-factor statistic analysis. The structures of the inhibitors are as follows: 1FKN, Glu-Val-Asn-Leu w Ala-Ala-Phe, where w represents transition-state isostere hydroxyethylene; 1M4H, Glu-Leu-Asp-Leu w Ala-Val-Glu-Phe; 1XN3, Lys-ThrGlu-Glu-Ile-Ser-Val-Asn-Sta-Val-Ala-Glu-Phe, where Sta is statine; 2ZHR, Glu-Val-Asn-Leu w Ala-Glu-Phe; and1XN2, Trp-Trp-Ser-Glu-Val-Asn-Leu w Ala-AlaGlu-Phe. For each protease-ligand complex in a crystallography asymmetric unit, residues of the peptide ligand were identified visually and assigned subsites from P 4 to P 4 0 accordingly. The average B-factor of each subsite was calculated for the side chain. Before comparing the average B-factors of each subsite from different crystal structures, a statistical normalization was performed with the following equation.
where N is the number of all atoms from the refined structure of a given PDB file; B is the average B-factor of all main-chain atoms (which are supposed to be refined more reliably) from the same PDB file. B is the B-factor to be normalized; here, it is the average B-factor of a certain subsite. A value below zero indicates that this group of atoms is less mobile than the average B-factor of main-chain atoms, and a value above zero indicates that this group of atoms is more mobile than the average.
